Appili Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 13
Employees
  • Stock Symbol
  • APLI
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.86
  • (As of Friday Closing)

Appili Therapeutics General Information

Description

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TSE
Primary Office
  • 1344 Summer Street
  • Suite 21
  • Halifax, Nova Scotia B3H 0A8
  • Canada
+1 (902) 000-0000

Appili Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Appili Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.86 $0.87 $0.35 - $1.36 $54.5M 62.6M 135K -$0.12

Appili Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 44,152 21,156
Revenue 148 150 0 0
EBITDA (5,591) (4,049) (3,315) (2,921)
Net Income (5,603) (4,071) (3,299) (3,097)
Total Assets 17,722 7,879 5,119 5,568
Total Debt 757 709 838 861
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Appili Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Appili Therapeutics‘s full profile, request access.

Request a free trial

Appili Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective th
Drug Discovery
Halifax, Canada
13 As of 2020
000.00
000000000 000.00

00000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000 000000000
Exton, PA
000 As of 0000
0000
0000 0000-00-00
000000&0 0000

00000 00

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000000
Boulder, CO
000 As of 0000
00000
00.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Appili Therapeutics Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Morphotek Formerly VC-backed Exton, PA 000 0000 000000&0 0000
00000 000000000 Formerly VC-backed Boulder, CO 000 00000 000000&0 00000
00000 00000 000000 Venture Capital-Backed Geneva, Switzerland 00 00000 0000000000 0 00000
00000 000000000000 Formerly VC-backed South San Francisco, CA 000 000.00 000000 - 000 000.00
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
You’re viewing 5 of 31 competitors. Get the full list »

Appili Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Armand Balboni Ph.D Chief Executive Officer & Board Member
Kevin Sullivan Chief Executive Officer & Board Member
Kimberly Stephens Chief Financial Officer, Finance
Don Cilla Chief Development Officer
Myriam Triest Executive
You’re viewing 5 of 9 executive team members. Get the full list »

Appili Therapeutics Board Members (14)

Name Representing Role Since
Armand Balboni Ph.D Appili Therapeutics Chief Executive Officer & Board Member 000 0000
Brian Bloom Bloom Burton & Co. Board Member 000 0000
Ian Mortimer Self Chairman & Board Member 000 0000
John Holyoake Ph.D Bloom Burton & Co. Board Member 000 0000
Juergen Froehlich MD Appili Therapeutics Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Appili Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Appili Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000 (0 21-Nov-2019 000000000 00000 00 Buildings and Property 00000 00000000
To view Appili Therapeutics’s complete investments history, request access »